ReviewCurrent atherosclerosis reports2020

Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.

Shizuya Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.